lactic acid has been researched along with Amyloid Deposits in 4 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As nattokinase is a protein, its stability restricts its usage to a greater extent, but this limitation can be overcome by nanoencapsulation." | 1.46 | Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ ( Al-Abbasi, FA; Anwar, F; Bhatt, PC; Kumar, V; Panda, BP; Verma, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, N | 1 |
| Ziyatdinova, S | 1 |
| Gureviciene, I | 1 |
| Tanila, H | 1 |
| Bhatt, PC | 1 |
| Verma, A | 1 |
| Al-Abbasi, FA | 1 |
| Anwar, F | 1 |
| Kumar, V | 1 |
| Panda, BP | 1 |
| Hartmann, J | 1 |
| Kiewert, C | 1 |
| Klein, J | 1 |
| Bero, AW | 1 |
| Yan, P | 1 |
| Roh, JH | 1 |
| Cirrito, JR | 1 |
| Stewart, FR | 1 |
| Raichle, ME | 1 |
| Lee, JM | 1 |
| Holtzman, DM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid[NCT03954210] | 200 participants (Anticipated) | Interventional | 2019-08-27 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for lactic acid and Amyloid Deposits
| Article | Year |
|---|---|
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.
Topics: 3-Hydroxybutyric Acid; Action Potentials; Alzheimer Disease; Animals; Anticonvulsants; Atropine; Dis | 2020 |
Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antifibrinolytic Agents; Calorimetry, Differential Scannin | 2017 |
Neurotransmitters and energy metabolites in amyloid-bearing APP(SWE)xPSEN1dE9 Mouse Brain.
Topics: Acetylcholine; Amyloid; Animals; Brain; Cerebral Cortex; Choline; Cholinesterases; Energy Metabolism | 2010 |
Neuronal activity regulates the regional vulnerability to amyloid-β deposition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cerebral Cortex; | 2011 |